Literature DB >> 12021321

Development and characterization of bovine x human hybrid cell lines that efficiently support the replication of both wild-type bovine and human adenoviruses and those with E1 deleted.

Alberto L van Olphen1, Suresh K Mittal.   

Abstract

The 293 cell line that was generated by transforming human embryonic kidney cells with human adenovirus type 5 (HAV5) early region 1 (E1) sequences is an excellent host for generating and growing HAV5 recombinants with E1 deleted, but it does not support the replication of bovine adenovirus type 3 (BAV3). Madin-Darby bovine kidney (MDBK), an established bovine cell line, is an excellent host for growing and plaquing BAV3. For the purpose of combining the unique characteristics of these two cell lines (293 and MDBK), we generated a number of bovine x human hybrid (BHH) cell lines. Comparison of three BHH hybrid clones-BHH3, BHH8, and BHH2C-with 293-Puro (puromycin-resistant 293 cells) and MDBK-Neo (G418-resistant MDBK cells) cell lines for total cellular DNA content, species-specific surface markers, isoenzyme analysis, and karyotyping indicate that they are hybrid in nature. BHH clones constitutively expressed the E1 proteins (E1A, E1B-21kDa, and E1B-55kDa) of HAV5 and efficiently supported the replication of both wild-type and replication-incompetent bovine or human adenoviruses. Transient gene expression experiments with a plasmid encoding the bacterial beta-galactosidase gene demonstrated that BHH cell hybrids seem to have better transfection efficiencies than either of the parental cell lines. These cell lines will be useful for isolating and growing replication-competent human or bovine adenovirus recombinants with E1 deleted and for the study of cellular or viral factors important for viral replication. The development of somatic cell hybrids appears to be a simple way of combining some of the desirable characteristics present separately in two parental cell lines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021321      PMCID: PMC136187          DOI: 10.1128/jvi.76.12.5882-5892.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Epitope-specific cytotoxic T lymphocyte induction by minigene DNA immunization.

Authors:  A Iwasaki; C S Dela Cruz; A R Young; B H Barber
Journal:  Vaccine       Date:  1999-04-09       Impact factor: 3.641

Review 2.  Production of first generation adenovirus vectors: a review.

Authors:  X Danthinne; M J Imperiale
Journal:  Gene Ther       Date:  2000-10       Impact factor: 5.250

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

4.  Characterization of bovine adenovirus type 3 E1 proteins and isolation of E1-expressing cell lines.

Authors:  Alberto L van Olphen; Suresh K Tikoo; Suresh K Mittal
Journal:  Virology       Date:  2002-03-30       Impact factor: 3.616

5.  Biodegradable alginate microspheres as a delivery system for naked DNA.

Authors:  N Aggarwal; H HogenEsch; P Guo; A North; M Suckow; S K Mittal
Journal:  Can J Vet Res       Date:  1999-04       Impact factor: 1.310

6.  Novel human gene transfer vectors: evaluation of wild-type and recombinant animal adenoviruses in human-derived cells.

Authors:  U B Rasmussen; M Benchaibi; V Meyer; Y Schlesinger; K Schughart
Journal:  Hum Gene Ther       Date:  1999-11-01       Impact factor: 5.695

7.  Replication-defective bovine adenovirus type 3 as an expression vector.

Authors:  P S Reddy; N Idamakanti; Y Chen; T Whale; L A Babiuk; M Mehtali; S K Tikoo
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

8.  Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion.

Authors:  G Köhler; C Milstein
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

9.  Polyethylene glycol (PEG) in the production of mammalian somatic cell hybrids.

Authors:  G Pontecorvo
Journal:  Cytogenet Cell Genet       Date:  1976

10.  Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.

Authors:  A Krishan
Journal:  J Cell Biol       Date:  1975-07       Impact factor: 10.539

View more
  15 in total

1.  155R is a novel structural protein of bovine adenovirus type 3, but it is not essential for virus replication.

Authors:  Ahmed O Hassan; Sai V Vemula; Anurag Sharma; Dinesh S Bangari; Krishna K Mishra; Suresh K Mittal
Journal:  J Gen Virol       Date:  2017-04-27       Impact factor: 3.891

2.  Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy.

Authors:  Ekramy E Sayedahmed; Rashmi Kumari; Shruti Shukla; Ahmed O Hassan; Sulma I Mohammed; Ian A York; Shivaprakash Gangappa; Suryaprakash Sambhara; Suresh K Mittal
Journal:  Vaccine       Date:  2018-09-25       Impact factor: 3.641

3.  Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time.

Authors:  Sai V Vemula; Omar Amen; Jacqueline M Katz; Ruben Donis; Suryaprakash Sambhara; Suresh K Mittal
Journal:  Virus Res       Date:  2013-09-17       Impact factor: 3.303

4.  EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model.

Authors:  Manish Tandon; Sai V Vemula; Anurag Sharma; Yadvinder S Ahi; Shalini Mittal; Dinesh S Bangari; Suresh K Mittal
Journal:  J Gene Med       Date:  2012-02       Impact factor: 4.565

5.  Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line.

Authors:  Samir Ali; Charles Pellerin; Daniel Lamarre; George Kukolj
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

6.  Adenoviral vector expressing murine β-defensin 2 enhances immunogenicity of an adenoviral vector based H5N1 influenza vaccine in aged mice.

Authors:  Sai V Vemula; Aseem Pandey; Neetu Singh; Jacqueline M Katz; Ruben Donis; Suryaprakash Sambhara; Suresh K Mittal
Journal:  Virus Res       Date:  2013-07-23       Impact factor: 3.303

7.  Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus.

Authors:  Neetu Singh; Aseem Pandey; Lakshmi Jayashankar; Suresh K Mittal
Journal:  Mol Ther       Date:  2008-02-26       Impact factor: 11.454

8.  Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine.

Authors:  Aseem Pandey; Neetu Singh; Sai V Vemula; Laurent Couëtil; Jacqueline M Katz; Ruben Donis; Suryaprakash Sambhara; Suresh K Mittal
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

9.  Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses.

Authors:  A Sharma; M Tandon; Y S Ahi; D S Bangari; R Vemulapalli; S K Mittal
Journal:  Gene Ther       Date:  2010-02-18       Impact factor: 5.250

10.  Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness.

Authors:  Sai V Vemula; Yadvinder S Ahi; Anne-Marie Swaim; Jacqueline M Katz; Ruben Donis; Suryaprakash Sambhara; Suresh K Mittal
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.